Chronic allograft dysfunction is characterized by what type of immune response?

Chronic allograft dysfunction is characterized by what type of immune response?

• A. Type I hypersensitivity reaction
• B. Humoral and cellular hypersensitivity reactions
• C. Immediate hypersensitivity response
• D. Autoimmune reaction

Answer: (B)

Chronic allograft dysfunction is primarily characterized by humoral and cellular hypersensitivity reactions. This condition develops as a result of the immune system's ongoing response to the transplanted tissue over time. The humoral aspect refers to the production of antibodies against donor antigens, which can lead to chronic rejection characterized by antibody-mediated injury to the graft. This antibody response can lead to processes such as graft arteriosclerosis, where blood vessels supplying the transplant become narrowed and obstructed. On the cellular side, cellular hypersensitivity involves T-lymphocytes that recognize donor antigens presented by antigen-presenting cells. This results in inflammatory processes that contribute to graft injury. Over time, these combined immune responses can lead to the gradual loss of function of the transplanted organ. In summary, chronic allograft dysfunction is a complex interplay of both humoral (antibody-mediated) and cellular (T cell-mediated) immune responses, which continuously target and damage the transplanted tissue, resulting in graft dysfunction.

Chronic allograft dysfunction is primarily characterized by humoral and cellular hypersensitivity reactions. This condition develops as a result of the immune system's ongoing response to the transplanted tissue over time.

The humoral aspect refers to the production of antibodies against donor antigens, which can lead to chronic rejection characterized by antibody-mediated injury to the graft. This antibody response can lead to processes such as graft arteriosclerosis, where blood vessels supplying the transplant become narrowed and obstructed.

On the cellular side, cellular hypersensitivity involves T-lymphocytes that recognize donor antigens presented by antigen-presenting cells. This results in inflammatory processes that contribute to graft injury. Over time, these combined immune responses can lead to the gradual loss of function of the transplanted organ.

In summary, chronic allograft dysfunction is a complex interplay of both humoral (antibody-mediated) and cellular (T cell-mediated) immune responses, which continuously target and damage the transplanted tissue, resulting in graft dysfunction.